PYCARD and pancreatic adenocarcinoma: Similar conclusions were found in lung cancer [12], while in pancreatic adenocarcinoma, PYCARD expression was increased in 90% of tumor samples compared to adjacent normal tissue, and elevated PYCARD expression was associated with a poorer prognosis [14].